Aquarius Surgical Technologies Inc. ASTI
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.39% | 0.46% | -33.37% | -58.36% | -53.63% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.39% | 0.46% | -33.37% | -58.36% | -53.63% |
| Cost of Revenue | 10.36% | -3.47% | -35.81% | -59.47% | -38.60% |
| Gross Profit | 8.26% | 3.80% | -31.08% | -57.36% | -61.66% |
| SG&A Expenses | -47.57% | -48.13% | -49.57% | -21.33% | -19.16% |
| Depreciation & Amortization | -67.66% | -46.19% | -27.27% | -12.89% | -12.61% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -44.63% | -44.98% | -47.61% | -25.07% | -20.58% |
| Operating Income | 53.94% | 52.57% | 50.22% | 15.26% | 9.44% |
| Income Before Tax | -600.84% | 44.02% | -25.55% | 6.53% | 73.18% |
| Income Tax Expenses | 309.09% | 309.09% | 7.69% | 7.69% | -78.85% |
| Earnings from Continuing Operations | -598.79% | 43.55% | -25.41% | 6.41% | 73.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -598.79% | 43.55% | -25.41% | 6.41% | 73.23% |
| EBIT | 53.94% | 52.57% | 50.22% | 15.26% | 9.44% |
| EBITDA | 65.76% | 53.33% | 50.50% | 15.29% | 9.29% |
| EPS Basic | -584.48% | 43.56% | -25.42% | 6.19% | 72.64% |
| Normalized Basic EPS | 23.70% | 22.70% | 26.80% | 5.71% | -1.50% |
| EPS Diluted | -584.48% | 43.56% | -25.42% | 6.19% | 72.64% |
| Normalized Diluted EPS | 23.70% | 22.70% | 26.80% | 5.71% | -1.50% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |